Moderna, Inc. (MRNA) Announced Q1 2026 Earnings on May 1, 2026, Reporting "total revenue was $400 million".
Moderna announced Q1 2026 financial results, with total revenue of $400 million and a net loss of $1.3 billion. The company reported ending the quarter with $7.5 billion in cash and investments, and highlighted the EU approval of mCOMBRIAX, their first flu plus COVID combo…